| Added by | mollevi |
|---|---|
| Group name | EquipeJC |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), Vienna, Austria. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts. Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), Vienna, Austria. Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. Uwe.Rix@moffitt.org. alt-title: Molecular cancer therapeutics number: 11 accession-num: 25189542 |
| Tags | _EndnoteXML import |
| Date Added | 2018/11/14 - 11:48:35 |
| Date Modified | 2018/11/14 - 11:48:35 |
| Parent item | Identification of kinase inhibitor targets in the lung cancer microenvironment by chemical and phosphoproteomics |
Institut de Recherche en Cancérologie de
